Michel P. de Baar

680 citations

16 papers · 511 indexed · h-index 12

Virology top 2%
- HIV Research and Treatment 15
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 14
- HIV/AIDS Research and Interventions 4
Emergency Medicine top 10%
- HIV-related health complications and treatments 4
Hepatology
- Hepatitis C virus research 2
Epidemiology
Ecology
- Bacteriophages and microbial interactions 2
Molecular Biology
- RNA Interference and Gene Delivery 1
Immunology
- interferon and immune responses 1

Co-authors: Anthony de Ronde Jaap Goudsmit Margreet Bakker Bob van Gemen Esther de Rooij Rob Schuurman Georgios Pollakis Paul Cleary
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: PLoS ONE (1 paper)Journal of Clinical Microbiology (6 papers)The Journal of Infectious Diseases (2 papers)
Partner nations: Netherlands United States Ethiopia

In The Last Decade

Michel P. de Baar

16 papers receiving 490 citations

Peers

Countries citing papers authored by Michel P. de Baar

Since Specialization

Citations

This map shows the geographic impact of Michel P. de Baar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel P. de Baar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel P. de Baar more than expected).

Fields of papers citing papers by Michel P. de Baar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel P. de Baar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel P. de Baar. The network helps show where Michel P. de Baar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michel P. de Baar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel P. de Baar Line = papers co-authored together Michel P. de Baar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1 PLoS ONE ·Alexey A. Nabatov,Georgios Pollakis,Thomas Linnemann,William A. Paxton,Michel P. de Baar	2007	35
2	Mitochondrial DNA Decline in T Cells of HIV‐1 Seroconverters May Be Dependent on Immune Activation The Journal of Infectious Diseases ·Miriam Casula,Nienke Vrisekoop,Ferdinand W.N.M. Wit,Michel P. de Baar,Anthony de Ronde,Frank Miedema,Peter Reiss	2007	10
3	Use of Dried Spots of Whole Blood, Plasma, and Mother's Milk Collected on Filter Paper for Measurement of Human Immunodeficiency Virus Type 1 Burden Journal of Clinical Microbiology ·Workenesh Ayele,Rob Schuurman,Tsehaynesh Messele,Wendelien Dorigo‐Zetsma,Yohannes Mengistu,Jaap Goudsmit,William A. Paxton,Michel P. de Baar,Georgios Pollakis	2007	35
4	Real-Time Nucleic Acid Sequence–Based Amplification Assay to Quantify Changes in Mitochondrial DNA Concentrations in Cell Cultures and Blood Cells from HIV-Infected Patients Receiving Antiviral Therapy Clinical Chemistry ·Eveline C. Timmermans,Pablo Tebas,Jos P.N. Ruiter,Ronald J. A. Wanders,Anthony de Ronde,Michel P. de Baar	2006	22
5	Infection with HIV‐1 Induces a Decrease in mtDNA The Journal of Infectious Diseases ·Miriam Casula,Irene Bosboom‐Dobbelaer,Karlijn Smolders,Sigrid A. Otto,Margreet Bakker,Michel P. de Baar,Peter Reiss,Anthony de Ronde	2005	49
6	Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, Malawi Tropical Medicine & International Health ·Joep J. van Oosterhout,Neena Bodasing,Johnstone J. Kumwenda,Cooper Nyirenda,Jane Mallewa,Paul Cleary,Michel P. de Baar,Rob Schuurman,David M. Burger,Eduard E. Zijlstra	2005	116
7	Mitochondrial Dna Depletion in HIV-Infected Patients is More Pronounced with Chronic Hepatitis C and Enhanced following Treatment with Pegylated Interferon plus Ribavirin Antiviral Therapy ·Carmen de Mendoza,Matilde Sánchez‐Conde,Eveline C. Timmermans,Marije Buitelaar,Michel P. de Baar,Juan González‐Lahoz,Vincent Soriano	2005	14
8	Surveillance technology for HIV-1 subtype C in Ethiopia: An env-based NASBA molecular beacon assay to discriminate between subcluster C and C′ Journal of Virological Methods ·Workenesh Ayele,Michel P. de Baar,Jaap Goudsmit,Aletta Kliphuis,Tesfaye Tilahun,Wendelien Dorigo‐Zetsma,Dawit Wolday,Almaz Abebe,Yohannes Mengistu,Georgios Pollakis	2005	7
9	Development of a Nucleic Acid Sequence-Based Amplification Assay That Uses gag -Based Molecular Beacons To Distinguish between Human Immunodeficiency Virus Type 1 Subtype C and C′ Infections in Ethiopia Journal of Clinical Microbiology ·Workenesh Ayele,Georgios Pollakis,Almaz Abebe,Bitew Fisseha,Belete Tegbaru,Girma Tesfaye,Yohannes Mengistu,Dawit Wolday,Bob van Gemen,Jaap Goudsmit,Wendelien Dorigo‐Zetsma,Michel P. de Baar	2004	17
10	HIV Type 1 C and C′ Subclusters Based on Long Terminal Repeat Sequences in the Ethiopian HIV Type 1 Subtype C Epidemic AIDS Research and Human Retroviruses ·Michel P. de Baar,Almaz Abebe,Aletta Kliphuis,Girma Tesfaye,Jaap Goudsmit,Georgios Pollakis	2003	5
11	One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG Journal of Clinical Microbiology ·Michel P. de Baar,Eveline C. Timmermans,Margreet Bakker,Esther de Rooij,Bob van Gemen,Jaap Goudsmit	2001	41
12	Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O Journal of Clinical Microbiology ·Michel P. de Baar,Maaike W. van Dooren,Esther de Rooij,Margreet Bakker,Bob van Gemen,Jaap Goudsmit,Anthony de Ronde	2001	60
13	Natural Residues versus Antiretroviral Drug-Selected Mutations in HIV Type 1 Group O Reverse Transcriptase and Protease Related to Virological Drug Failure in Vivo AIDS Research and Human Retroviruses ·Michel P. de Baar,Wouter Janssens,Anthony de Ronde,Katrien Fransen,Robert Colebunders,Luc Kestens,Guido van der Groen,Jaap Goudsmit	2000	19
14	Subtype-Specific Sequence Variation of the HIV Type 1 Long Terminal Repeat and Primer-Binding Site AIDS Research and Human Retroviruses ·Michel P. de Baar,Anthony de Ronde,Ben Berkhout,Marion Cornelissen,K H Van Der Horn,Audrey M. van der Schoot,F. de Wolf,Vladimir V. Lukashov,Jaap Goudsmit	2000	40
15	Detection of Human Immunodeficiency Virus Type 1 Nucleocapsid Protein p7 In Vitro and In Vivo Journal of Clinical Microbiology ·Michel P. de Baar,Karin Horn,Jaap Goudsmit,Anthony de Ronde,F. de Wolf	1999	5
16	Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target Journal of Clinical Microbiology ·Michel P. de Baar,Audrey M. van der Schoot,Jaap Goudsmit,F. Jacobs,Ron Ehren,Karin Horn,Peter Oudshoorn,Frank de Wolf,Anthony de Ronde	1999	36

About Michel P. de Baar

Michel P. de Baar is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 16 papers that have together received 511 indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (4 papers), Hepatitis C virus research (2 papers), Bacteriophages and microbial interactions (2 papers), RNA Interference and Gene Delivery (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Virology (292 citations), Infectious Diseases (325 citations) and Emergency Medicine (79 citations). Michel P. de Baar has collaborated with scholars based in Netherlands, United States and Ethiopia. Frequent co-authors include Anthony de Ronde, Jaap Goudsmit, Margreet Bakker, Bob van Gemen, Esther de Rooij, Rob Schuurman, Georgios Pollakis, Paul Cleary, David M. Burger and Johnstone J. Kumwenda. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact